SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject3/22/2003 4:59:16 PM
From: scaram(o)uche  Read Replies (2) of 469
 
J Nanobiotechnology. 2003; 1 (1): 1

Self-assembly of proteins and their nucleic acids
Graham Fletcher,1 Sean Mason,1 Jon Terrett,1 and Mikhail Soloviev1

1Oxford GlycoSciences (UK) Ltd, Abingdon, Oxon OX14 3YS, United Kingdom

Corresponding author.

Graham Fletcher: Graham.Fletcher@ogs.co.uk; Sean Mason: Sean.Mason@ogs.co.uk; Jon Terrett: Jon.Terrett@ogs.co.uk; Mikhail Soloviev: Mikhail.Soloviev@ogs.co.uk

We have developed an artificial protein scaffold, herewith called a protein vector, which allows linking of an in-vitro synthesised protein to the nucleic acid which encodes it through the process of self-assembly. This protein vector enables the direct physical linkage between a functional protein and its genetic code. The principle is demonstrated using a streptavidin-based protein vector (SAPV) as both a nucleic acid binding pocket and a protein display system. We have shown that functional proteins or protein domains can be produced in vitro and physically linked to their DNA in a single enzymatic reaction. Such self-assembled protein-DNA complexes can be used for protein cloning, the cloning of protein affinity reagents or for the production of proteins which self-assemble on a variety of solid supports. Self-assembly can be utilised for making libraries of protein-DNA complexes or for labelling the protein part of such a complex to a high specific activity by labelling the nucleic acid associated with the protein. In summary, self-assembly offers an opportunity to quickly generate cheap protein affinity reagents, which can also be efficiently labelled, for use in traditional affinity assays or for protein arrays instead of conventional antibodies.

pubmedcentral.gov

(volume 1, issue 1, page 1)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext